Texas Yale Capital Corp. decreased its position in shares of HCP, Inc. (NYSE:HCP) by 58.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 15,830 shares of the real estate investment trust’s stock after selling 21,875 shares during the quarter. Texas Yale Capital Corp.’s holdings in HCP were worth $413,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Advisory Services Network LLC lifted its position in shares of HCP by 4.1% during the 2nd quarter. Advisory Services Network LLC now owns 3,782 shares of the real estate investment trust’s stock valued at $121,000 after buying an additional 150 shares in the last quarter. Fieldpoint Private Securities LLC purchased a new position in shares of HCP during the 3rd quarter valued at approximately $147,000. Penserra Capital Management LLC purchased a new position in shares of HCP during the 3rd quarter valued at approximately $163,000. Koch Industries Inc. purchased a new position in shares of HCP during the 2nd quarter valued at approximately $208,000. Finally, Cetera Investment Advisers purchased a new position in shares of HCP during the 2nd quarter valued at approximately $208,000. 90.23% of the stock is currently owned by institutional investors and hedge funds.

HCP, Inc. (HCP) opened at $22.80 on Wednesday. The company has a quick ratio of 0.61, a current ratio of 0.61 and a debt-to-equity ratio of 1.17. The firm has a market capitalization of $10,719.13, a price-to-earnings ratio of 20.54, a price-to-earnings-growth ratio of 4.13 and a beta of 0.27. HCP, Inc. has a fifty-two week low of $21.98 and a fifty-two week high of $33.67.

HCP (NYSE:HCP) last announced its quarterly earnings data on Tuesday, February 13th. The real estate investment trust reported $0.48 earnings per share for the quarter, beating analysts’ consensus estimates of $0.17 by $0.31. The company had revenue of $443.30 million for the quarter, compared to analyst estimates of $448.54 million. HCP had a return on equity of 8.85% and a net margin of 27.31%. The firm’s revenue for the quarter was down 17.9% on a year-over-year basis. During the same quarter last year, the firm posted $0.59 EPS. equities research analysts forecast that HCP, Inc. will post 1.94 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 2nd. Shareholders of record on Thursday, February 15th will be issued a $0.37 dividend. The ex-dividend date of this dividend is Wednesday, February 14th. This represents a $1.48 dividend on an annualized basis and a yield of 6.49%. HCP’s payout ratio is currently 133.33%.

A number of research analysts have recently issued reports on the company. Stifel Nicolaus decreased their target price on HCP from $29.00 to $27.00 and set a “buy” rating on the stock in a research report on Wednesday. Jefferies Group reiterated a “hold” rating and set a $26.00 target price on shares of HCP in a research report on Tuesday. ValuEngine lowered HCP from a “buy” rating to a “hold” rating in a research report on Friday, February 2nd. JPMorgan Chase & Co. upgraded HCP from a “neutral” rating to an “overweight” rating and set a $29.00 target price on the stock in a research report on Friday, December 15th. Finally, Zacks Investment Research upgraded HCP from a “sell” rating to a “hold” rating in a research report on Thursday, November 9th. Four research analysts have rated the stock with a sell rating, eleven have issued a hold rating and four have issued a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus price target of $29.50.

COPYRIGHT VIOLATION NOTICE: This piece was posted by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are viewing this piece on another domain, it was stolen and reposted in violation of international trademark & copyright laws. The correct version of this piece can be viewed at https://theolympiareport.com/2018/02/14/texas-yale-capital-corp-has-413000-stake-in-hcp-inc-hcp.html.

HCP Profile

HCP, Inc is a self-administered real estate investment trust. The Company invests in real estate serving the healthcare industry in the United States. The Company’s segments include senior housing triple-net (SH NNN), senior housing operating portfolio (SHOP), life science and medical office. Its senior housing facilities include independent living facilities, assisted living facilities, memory care facilities, care homes, and continuing care retirement communities.

Want to see what other hedge funds are holding HCP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCP, Inc. (NYSE:HCP).

Institutional Ownership by Quarter for HCP (NYSE:HCP)

Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.